Skip directly to content

As TAG marks 25 years of activism and advocacy, our mission is more vital than ever. A quarter-century of progress promoting research, prevention, and treatment critical to ending the HIV/AIDS, tuberculosis (TB), and hepatitis C (HCV) epidemics is at risk.

We are more determined than ever to shape policy toward defeating HIV and ending the TB and HCV epidemics, as quickly as possible.

To achieve our goals in the current challenging political environment, TAG has launched a new initiative, the 25th Anniversary Campaign, that will make our powerful and relentless voice stronger than ever to:

Fourteen health and social justice organizations from across the U.S. wish to celebrate the people-powered effort behind UnitedHealthcare responding so swiftly to demands that they improve access to the HIV drug Truvada for pre-exposure prophylaxis (PrEP), a medical intervention that prevents HIV infection. On Friday, Aug. 4, UnitedHealthcare received a joint letter from this coalition objecting to new prior authorization rules put in place for access to PrEP effective July 1. These burdensome rules required patients to request access to PrEP every three months, denied claims for some based on